Insulin-containing polymer composition for oral administration
US5698515A · kind A · utility
8Cited by
9References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 22, 1995 |
| Grant date | Dec 16, 1997 |
| Priority date | — |
| Expiry date | Mar 22, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/46
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An insulin-containing polymer composition intended for the oral administration of insulin, which comprises a hydrophilic polymer modified with an inhibitor of proteolytic enzyme, insulin and water, wherein the inhibitor of proteolytic enzymes is ovomucoid isolated from duck or turkey egg whites.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.